These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15653674)

  • 1. SOCS-3 induces myoblast differentiation.
    Spangenburg EE
    J Biol Chem; 2005 Mar; 280(11):10749-58. PubMed ID: 15653674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-induced transcriptional activity of the skeletal alpha-actin gene is regulated by signaling mechanisms linked to voltage-gated calcium channels during myoblast differentiation.
    Spangenburg EE; Bowles DK; Booth FW
    Endocrinology; 2004 Apr; 145(4):2054-63. PubMed ID: 14684598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.
    Yu CR; Mahdi RM; Ebong S; Vistica BP; Gery I; Egwuagu CE
    J Biol Chem; 2003 Aug; 278(32):29752-9. PubMed ID: 12783879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction.
    Inaba M; Saito H; Fujimoto M; Sumitani S; Ohkawara T; Tanaka T; Kouhara H; Kasayama S; Kawase I; Kishimoto T; Naka T
    Biochem Biophys Res Commun; 2005 Mar; 328(4):953-61. PubMed ID: 15707970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early growth response-1 regulates lipopolysaccharide-induced suppressor of cytokine signaling-1 transcription.
    Mostecki J; Showalter BM; Rothman PB
    J Biol Chem; 2005 Jan; 280(4):2596-605. PubMed ID: 15545275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells.
    Baetz A; Frey M; Heeg K; Dalpke AH
    J Biol Chem; 2004 Dec; 279(52):54708-15. PubMed ID: 15491991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells.
    Ouyang X; Fujimoto M; Nakagawa R; Serada S; Tanaka T; Nomura S; Kawase I; Kishimoto T; Naka T
    J Cell Physiol; 2006 May; 207(2):428-36. PubMed ID: 16419040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS; Anderson BG; Plymate SR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
    Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
    Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
    Deng X; Ewton DZ; Mercer SE; Friedman E
    J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cAMP response element binding protein (CREB) is activated by insulin-like growth factor-1 (IGF-1) and regulates myostatin gene expression in skeletal myoblast.
    Zuloaga R; Fuentes EN; Molina A; Valdés JA
    Biochem Biophys Res Commun; 2013 Oct; 440(2):258-64. PubMed ID: 24064350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
    Ueki K; Kondo T; Kahn CR
    Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells.
    Ostrovsky O; Bengal E; Aronheim A
    J Biol Chem; 2002 Oct; 277(42):40043-54. PubMed ID: 12171923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival.
    Duval D; Reinhardt B; Kedinger C; Boeuf H
    FASEB J; 2000 Aug; 14(11):1577-84. PubMed ID: 10928992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
    Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the insulin-like growth factor-II gene during myoblast differentiation.
    Kou K; Rotwein P
    Mol Endocrinol; 1993 Feb; 7(2):291-302. PubMed ID: 8469241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells.
    Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M
    J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.